KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Retained Earnings (2016 - 2025)

Amgen has reported Retained Earnings over the past 17 years, most recently at -$258.0 million for Q4 2025.

  • Quarterly results put Retained Earnings at -$258.0 million for Q4 2025, down 290.91% from a year ago — trailing twelve months through Dec 2025 was -$258.0 million (down 290.91% YoY), and the annual figure for FY2025 was -$258.0 million, down 290.91%.
  • Retained Earnings for Q4 2025 was -$258.0 million at Amgen, up from -$422.0 million in the prior quarter.
  • Over the last five years, Retained Earnings for AMGN hit a ceiling of -$66.0 million in Q4 2024 and a floor of -$29.6 billion in Q1 2022.
  • Median Retained Earnings over the past 5 years was -$22.9 billion (2021), compared with a mean of -$15.7 billion.
  • Peak annual rise in Retained Earnings hit 99.75% in 2024, while the deepest fall reached 20161.9% in 2024.
  • Amgen's Retained Earnings stood at -$24.6 billion in 2021, then decreased by 16.35% to -$28.6 billion in 2022, then grew by 7.24% to -$26.5 billion in 2023, then soared by 99.75% to -$66.0 million in 2024, then crashed by 290.91% to -$258.0 million in 2025.
  • The last three reported values for Retained Earnings were -$258.0 million (Q4 2025), -$422.0 million (Q3 2025), and -$25.7 billion (Q2 2025) per Business Quant data.